Developer docs
API playgroundTry for free, no card

Search company profiles

QT Sense

Full company profile

uuid0002a2r

Namestring
QT Sense
Legal namestring
QT Sense BV
Websiteurl
qtsense.com
Company typeenum
Private
Founded yearint
2024
Short descriptiontext

QT Sense is a Netherlands-based spinout from University Medical Center Groningen that develops the Quantum Nuova benchtop platform using fluorescent nanodiamond quantum sensors to detect free radicals in living cells in real time, serving academic researchers and pharmaceutical R&D teams.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGroningen, Netherlands
HQ citystring
Groningen
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
quantum biosensing platform, live cell analysis, fluorescent nanodiamond sensors, oxidative stress detection, drug discovery tools
Industry1 code
PRIMARYHDAGAHAH
Quantum Spectroscopy & Chemical/Biological Sensing
NAICS code4 codes
  • Analytical Laboratory Instrument Manufacturing334516
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing3345
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)541715
SIC code3 codes
  • Laboratory Analytical Instruments3826
  • Services-Commercial Physical & Biological Research8731
  • Surgical & Medical Instruments & Apparatus3841
Product category
Quantum Biosensing Instruments
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Quantum Nuova Instrument Sales
TypeHardware Sales
Description

Sale of the Quantum Nuova quantum biosensing platform hardware and system to research institutions, pharmaceutical companies, and healthcare facilities for drug discovery and diagnostic research applications.

qtsense.com
2Training and Support Services
TypeProfessional Services
Description

Hands-on training sessions, technical support, and ongoing customer success services including installation, validation, and application guidance for the Quantum Nuova platform.

qtsense.com
3Research Collaborations
TypeSubscription Recurring
Description

Collaborative research projects with academic and clinical partners, potentially including grant-funded research initiatives such as the ONCO-Q project for colorectal cancer diagnostics.

qtsense.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1Quantum Nuova
Description

A high-resolution biosensing platform that uses fluorescent nanodiamond quantum sensors to detect free radicals and oxidative stress in living cells at single-cell resolution in real time, enabling applications in drug discovery, cancer research, and diagnostics.

qtsense.com
Core offering1 text field

QT Sense develops and sells the Quantum Nuova platform, a benchtop quantum biosensing instrument that uses fluorescent nanodiamond sensors with Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at subcellular resolution in real time. The system is paired with Quantum Pulse proprietary software for instrument control and data analysis, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research. Installation, validation, hands-on training, and ongoing customer support are provided as part of the offering.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • Detects free radicals at nanomolar concentrations (1-10nM detection limits)
+5 more records
Product overview1 text field

QT Sense offers Quantum Nuova as its core flagship product—a quantum biosensing platform that combines fluorescent nanodiamond quantum sensors (containing NV centers) with advanced optics and embedded control systems to enable real-time, subcellular detection of free radicals in living cells. The platform is complemented by Quantum Pulse Software, which provides instrument control and automated data analysis. Together, these products enable researchers to monitor cellular stress, oxidative stress, and metabolic changes at single-cell resolution for applications in drug discovery, cancer research, sepsis diagnostics, and cardiovascular disease research.

Product and service1 record
1Quantum Nuova
CategoryCore biosensing instrument platform
Description

A high-resolution quantum biosensing platform that uses fluorescent nanodiamond sensors containing Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at single-cell and subcellular resolution in real time. It enables real-time monitoring of oxidative stress, metabolic shifts, and cellular stress responses, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research.

Scale indicator9 records

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-06-01
Description

First installation of QT Sense's quantum biosensor installation at Leiden with Dr. Alireza Mashaghi's laboratory, enabling detection of rapid chemical changes in cells for drug discovery research.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Partner in the ONCO-Q €2M JTF-funded project for precision oncology diagnostics using quantum sensing technology.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-10-01
Description

Partner in the ONCO-Q project consortium focused on advancing colorectal cancer diagnostics through quantum sensing.

4University Medical Center Groningen (UMCG)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

UMCG's Emergency Department installed Quantum Nuova in September 2025 for sepsis research under Prof. Hjalmar Bouma's leadership. UMCG is QT Sense's founding institution as a spinout. Also collaborates on ONCO-Q €2M project for colorectal cancer diagnostics.

qtsense.com
5Ravi Puvvala (Bangalore, India)
Strategic tierEmergingTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Partnership with Bangalore-based researcher Ravi Puvvala's group for first Indian deployment of Quantum Nuova platform, focusing on real-time radical sensing applications.

qtsense.com
6Dr. Swaminathan (Tata IISc Medical School)
Strategic tierEmergingTypeStrategic or Co-development PartnerAnnounced on2025-09-01
Description

Collaboration with Tata IISc Medical School focusing on conditions like sepsis and acute kidney injury in India, exploring quantum biosensing applications.

qtsense.com
7Quantum Delta NL
Strategic tierCoreTypeOthers
Description

Part of the Stichting QDNL (Quantum Delta NL) ecosystem, a €615 million Dutch National Growth Fund programme establishing the Netherlands as a global leader in quantum technology. QT Sense is among the first applications from this initiative.

qtsense.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Qnami develops quantum sensing instruments based on NV centers in diamond for nanoscale magnetic imaging and biosensing. It is the most direct comparable to QT Sense in using diamond quantum sensors for life-science and bio-magnetic applications.

TypeBroad incumbent
Description

Bruker is a global analytical instruments leader spanning EPR (electron paramagnetic resonance) spectrometers and preclinical imaging systems, which overlap directly with QT Sense's free radical detection use case. It is the incumbent reference standard that QT Sense positions against in life-sciences research labs.

TypeBroad incumbent
Description

Thermo Fisher is the dominant analytical and life-sciences instrumentation company, providing flow cytometers, high-content imaging, and reagents used in cellular stress and oxidative stress research. It is the benchmark enterprise vendor QT Sense will compete with for pharma and biotech research budgets.

TypeBroad incumbent
Description

Agilent manufactures a broad range of analytical instruments (mass spec, chromatography, cell analysis) used by pharma and biotech research labs. It is relevant as a broad incumbent competitor for cellular analytical workflows that QT Sense targets.

TypeBroad incumbent
Description

Oxford Instruments' Andor division supplies high-sensitivity cameras, microscopy, and spectroscopy systems used in advanced bio-imaging and quantum sensing setups. It is comparable as a supplier of optical and detection instrumentation underpinning quantum biosensing research.

TypeBroad incumbent
Description

Sartorius provides cell analysis instruments and bioprocessing tools widely used in pharmaceutical R&D and cell-based assays. It is comparable as an incumbent life-sciences instrumentation vendor whose installed base QT Sense must displace for cell-based drug discovery applications.

TypeBroad incumbent
Description

ZEISS produces advanced optical microscopes and imaging platforms used in subcellular and live-cell imaging. Its super-resolution and confocal systems are an incumbent reference for the kind of high-resolution cellular analysis that Quantum Nuova is positioned to complement or substitute.

TypeBroad incumbent
Description

PerkinElmer/Revvity offers life-sciences reagents, imaging, and analytical instruments used in cell biology, oxidative stress, and diagnostics research. It is a broad incumbent peer in the analytical tools category serving QT Sense's target academic and pharma customers.

TypeEmerging player
Description

Quantum Diamonds is a deep-tech startup building quantum sensing solutions based on NV centers in diamond for biomedical and industrial applications. It is an emerging peer with overlapping technology roots and target applications in magnetic and biosensing.

TypeOthers
Description

Adamas Nanotechnologies is a leading manufacturer of fluorescent nanodiamonds (FNDs) used as the core sensing element in QT Sense's platform. It is a key enabling supplier and ecosystem partner rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

QT Sense

Quantum Biosensing Instrumentsqtsense.com

QT Sense is a Netherlands-based spinout from University Medical Center Groningen that develops the Quantum Nuova benchtop platform using fluorescent nanodiamond quantum sensors to detect free radicals in living cells in real time, serving academic researchers and pharmaceutical R&D teams.

QT Sense firmographics

Firmographics
Name
QT Sense
Legal name
QT Sense BV
Website
https://qtsense.com
Company type
Private
Founded year
2024
Operating status
Operating
Headcount range
11–50 employees
Short description
QT Sense is a Netherlands-based spinout from University Medical Center Groningen that develops the Quantum Nuova benchtop platform using fluorescent nanodiamond quantum sensors to detect free radicals in living cells in real time, serving academic researchers and pharmaceutical R&D teams.
Ownership category
akta.pro rank

QT Sense industry classification

Industry
Product category
Quantum Biosensing Instruments
NAICS
Analytical Laboratory Instrument Manufacturing (334516), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (3345), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)
SIC
Laboratory Analytical Instruments (3826), Services-Commercial Physical & Biological Research (8731), Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHDAGAHAH
Quantum Spectroscopy & Chemical/Biological Sensing

Keywords

  • Quantum biosensing platform
  • Live cell analysis
  • Fluorescent nanodiamond sensors
  • Oxidative stress detection
  • Drug discovery tools

Where QT Sense is headquartered

Location

Headquarters

HQ city
Groningen
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

QT Sense business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales, Supply Chain

Revenue model

  1. Quantum Nuova Instrument Sales: Sale of the Quantum Nuova quantum biosensing platform hardware and system to research institutions, pharmaceutical companies, and healthcare facilities for drug discovery and diagnostic research applications.
  2. Training and Support Services: Hands-on training sessions, technical support, and ongoing customer success services including installation, validation, and application guidance for the Quantum Nuova platform.
  3. Research Collaborations: Collaborative research projects with academic and clinical partners, potentially including grant-funded research initiatives such as the ONCO-Q project for colorectal cancer diagnostics.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels6 records

QT Sense product offering

Product offering

Core offering

QT Sense develops and sells the Quantum Nuova platform, a benchtop quantum biosensing instrument that uses fluorescent nanodiamond sensors with Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at subcellular resolution in real time. The system is paired with Quantum Pulse proprietary software for instrument control and data analysis, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research. Installation, validation, hands-on training, and ongoing customer support are provided as part of the offering.

Product overview

QT Sense offers Quantum Nuova as its core flagship product—a quantum biosensing platform that combines fluorescent nanodiamond quantum sensors (containing NV centers) with advanced optics and embedded control systems to enable real-time, subcellular detection of free radicals in living cells. The platform is complemented by Quantum Pulse Software, which provides instrument control and automated data analysis. Together, these products enable researchers to monitor cellular stress, oxidative stress, and metabolic changes at single-cell resolution for applications in drug discovery, cancer research, sepsis diagnostics, and cardiovascular disease research.

Differentiator

Problem solved

Functional benefit

Brands

  • Quantum Nuova: A high-resolution biosensing platform that uses fluorescent nanodiamond quantum sensors to detect free radicals and oxidative stress in living cells at single-cell resolution in real time, enabling applications in drug discovery, cancer research, and diagnostics.

Products and services

  • Quantum Nuova A high-resolution quantum biosensing platform that uses fluorescent nanodiamond sensors containing Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at single-cell and subcellular resolution in real time. It enables real-time monitoring of oxidative stress, metabolic shifts, and cellular stress responses, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research.

Quantifiable outcome

  • Detects free radicals at nanomolar concentrations (1-10nM detection limits)
  • +5 more outcomes

Companies that use QT Sense

Customer profile

Named customers6 records

Segments7 records

Ideal customer profiles3 records

QT Sense technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

QT Sense partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered core and emerging.

  • Leiden UniversitycoreStrategic or Co-development Partner · 1 June 2026First installation of QT Sense's quantum biosensor installation at Leiden with Dr. Alireza Mashaghi's laboratory, enabling detection of rapid chemical changes in cells for drug discovery research.
  • University of GroningencoreStrategic or Co-development Partner · 1 October 2025Partner in the ONCO-Q €2M JTF-funded project for precision oncology diagnostics using quantum sensing technology.
  • Healthy Ageing Business CooperativecoreStrategic or Co-development Partner · 1 October 2025Partner in the ONCO-Q project consortium focused on advancing colorectal cancer diagnostics through quantum sensing.
  • University Medical Center Groningen (UMCG)coreStrategic or Co-development Partner · 1 September 2025UMCG's Emergency Department installed Quantum Nuova in September 2025 for sepsis research under Prof. Hjalmar Bouma's leadership. UMCG is QT Sense's founding institution as a spinout. Also collaborates on ONCO-Q €2M project for colorectal cancer diagnostics.
  • Ravi Puvvala (Bangalore, India)emergingStrategic or Co-development Partner · 1 September 2025Partnership with Bangalore-based researcher Ravi Puvvala's group for first Indian deployment of Quantum Nuova platform, focusing on real-time radical sensing applications.
  • Dr. Swaminathan (Tata IISc Medical School)emergingStrategic or Co-development Partner · 1 September 2025Collaboration with Tata IISc Medical School focusing on conditions like sepsis and acute kidney injury in India, exploring quantum biosensing applications.
  • Quantum Delta NLcoreOthersPart of the Stichting QDNL (Quantum Delta NL) ecosystem, a €615 million Dutch National Growth Fund programme establishing the Netherlands as a global leader in quantum technology. QT Sense is among the first applications from this initiative.

Scale indicators9 records

Recent moves7 records

Expansion highlights6 records

QT Sense competitors and assessment

Company assessment

Direct peers

  • Qnami: Qnami develops quantum sensing instruments based on NV centers in diamond for nanoscale magnetic imaging and biosensing. It is the most direct comparable to QT Sense in using diamond quantum sensors for life-science and bio-magnetic applications.

Broad incumbents

  • Bruker: Bruker is a global analytical instruments leader spanning EPR (electron paramagnetic resonance) spectrometers and preclinical imaging systems, which overlap directly with QT Sense's free radical detection use case. It is the incumbent reference standard that QT Sense positions against in life-sciences research labs.
  • Thermo Fisher Scientific: Thermo Fisher is the dominant analytical and life-sciences instrumentation company, providing flow cytometers, high-content imaging, and reagents used in cellular stress and oxidative stress research. It is the benchmark enterprise vendor QT Sense will compete with for pharma and biotech research budgets.
  • Agilent Technologies: Agilent manufactures a broad range of analytical instruments (mass spec, chromatography, cell analysis) used by pharma and biotech research labs. It is relevant as a broad incumbent competitor for cellular analytical workflows that QT Sense targets.
  • Oxford Instruments (Andor): Oxford Instruments' Andor division supplies high-sensitivity cameras, microscopy, and spectroscopy systems used in advanced bio-imaging and quantum sensing setups. It is comparable as a supplier of optical and detection instrumentation underpinning quantum biosensing research.
  • Sartorius: Sartorius provides cell analysis instruments and bioprocessing tools widely used in pharmaceutical R&D and cell-based assays. It is comparable as an incumbent life-sciences instrumentation vendor whose installed base QT Sense must displace for cell-based drug discovery applications.
  • Carl Zeiss (ZEISS Research Microscopy Solutions): ZEISS produces advanced optical microscopes and imaging platforms used in subcellular and live-cell imaging. Its super-resolution and confocal systems are an incumbent reference for the kind of high-resolution cellular analysis that Quantum Nuova is positioned to complement or substitute.
  • PerkinElmer (Revvity): PerkinElmer/Revvity offers life-sciences reagents, imaging, and analytical instruments used in cell biology, oxidative stress, and diagnostics research. It is a broad incumbent peer in the analytical tools category serving QT Sense's target academic and pharma customers.

Emerging players

  • Quantum Diamonds (QDTI): Quantum Diamonds is a deep-tech startup building quantum sensing solutions based on NV centers in diamond for biomedical and industrial applications. It is an emerging peer with overlapping technology roots and target applications in magnetic and biosensing.

Others

  • Adamas Nanotechnologies: Adamas Nanotechnologies is a leading manufacturer of fluorescent nanodiamonds (FNDs) used as the core sensing element in QT Sense's platform. It is a key enabling supplier and ecosystem partner rather than a direct competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

QT Sense social profiles

Digital presence

QT Sense financial estimates

Financial estimate

Revenue estimate

Valuation estimate

QT Sense leadership team

Management profile

Number of profiles

Profiles2 records

QT Sense funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

QT Sense M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about QT Sense

What does QT Sense do?

QT Sense develops and sells the Quantum Nuova platform, a benchtop quantum biosensing instrument that uses fluorescent nanodiamond sensors with Nitrogen-Vacancy (NV) centers to detect, localize, and quantify free radical activity in living cells at subcellular resolution in real time. The system is paired with Quantum Pulse proprietary software for instrument control and data analysis, and is sold to pharmaceutical R&D teams, biotech firms, academic research labs, and clinical institutions for drug discovery, diagnostics development, and disease mechanism research. Installation, validation, hands-on training, and ongoing customer support are provided as part of the offering.

Is QT Sense a public or private company?

QT Sense is a private company. It is classified as venture growth investor backed and is currently operating.

When was QT Sense founded?

QT Sense was founded in 2024. It employs 11 to 50 people.

Where is QT Sense based?

QT Sense is headquartered in Groningen, Netherlands, in the Europe region.

How does QT Sense make money?

Three revenue lines are on record. Quantum Nuova Instrument Sales are the primary driver. The others are training and Support Services and research Collaborations.

Who are QT Sense's main competitors?

Qnami is listed as a direct peer. Broad incumbents are Bruker, Thermo Fisher Scientific, Agilent Technologies, Oxford Instruments (Andor), Sartorius, Carl Zeiss (ZEISS Research Microscopy Solutions) and PerkinElmer (Revvity). Quantum Diamonds (QDTI) is listed as an emerging player. Adamas Nanotechnologies is listed as an others.

Does QT Sense have an API?

No public API is recorded for QT Sense.

What industry is QT Sense in?

QT Sense's product category is Quantum Biosensing Instruments. Its primary akta.pro industry code is HDAGAHAH, Quantum Spectroscopy & Chemical/Biological Sensing. Its NAICS code is 334516 and its SIC code is 3826.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Quantum ZeitgeistBooz Allen Announces $25,000 Prize for Quantum’s Next Breakout CompanyBooz Allen Hamilton announced a $25,000 grand prize for the 2026 Quantum Startup Pitch Competition, to be held September 23–25, 2026 at The Hotel at the University of Maryland during Quantum World Congress 2026. The competition will provide mentorship from NEXT powered by Shulman Rogers and visibility to investors and government leaders, seeking early-stage companies applying quantum science across computing, sensing, and cybersecurity. Previous winners referenced include Canada's Phaseshift and the Netherlands' QT Sense, highlighting the international scope of the competition aimed at translating laboratory quantum research into practical, commercially viable solutions.Pulse 2.0QT Sense: €4 Million Raised To Advance Quantum Sensing Platform For Drug Discovery And Spatial BiologyQT Sense completed a €4 million funding round led by Cottonwood Technology Fund and QDNL Participations to enhance its quantum sensing platform for drug discovery and spatial biology. The investment aims to accelerate customer onboarding, drive adoption in the pharmaceutical industry, and expand manufacturing and technical capabilities.FinSMEsQT Sense Raises €4M in FundingQT Sense, a Groningen-based biotech startup founded in February 2024 as a spinout from University Medical Center Groningen, raised €4 million in a funding round led by Cottonwood Technology Fund with participation from QDNL Participations and an angel investor. The company also secured a €0.6 million ONCO-Q grant for oncology applications and an additional €0.4 million through the Quantum Forward Challenge. QT Sense plans to use the funds to expand operations and advance its Quantum Nouva diagnostic technology, which targets oxidative stress-induced conditions including cancer, male infertility, immune disorders, sepsis, and arthritis.Pulse 2.0QT Sense: €4 Million Raised To Advance Quantum Sensing For Drug Discovery And Spatial BiologyQT Sense closed a €4 million investment round led by Cottonwood Technology Fund to accelerate its quantum sensing platform for drug discovery and spatial biology. The proceeds will fund an AAA strategy to scale production-quality deployments and deepen platform capabilities. The company cites a multi-billion-euro opportunity in drug discovery.The Next WebQT Sense raises €4M to advance a quantum sensing platformQT Sense, a deep-tech biotech startup spun out of the University Medical Center Groningen in 2024, has secured €4 million in funding to accelerate its Quantum Nuova platform, which uses ultra-sensitive fluorescent nanodiamond quantum sensors to observe cellular processes in real time. The funding includes a €3 million seed investment led by Cottonwood Technology Fund, along with €600,000 from the ONCO-Q programme for cancer research and €400,000 through the Quantum Forward Challenge for collaborative deployments. The company plans to use the funding to advance its technology toward a ready-to-deploy discovery platform and apply it specifically to colorectal cancer research.EU-StartupsQT Sense raises €4 million to develop quantum platform for cancer, sepsis and arthritis researchGroningen-based BioTech startup QT Sense has raised €4 million in total funding — comprising a €3 million Seed round led by Cottonwood Technology Fund, a €600k ONCO-Q grant, and €400k through the Quantum Forward Challenge — to advance its Quantum Nuova platform for real-time tracking of cellular stress at single-cell resolution. The platform uses ultra-sensitive fluorescent nanodiamond quantum sensors to detect oxidative stress, metabolic shifts, and free radical kinetics in living cells, targeting research into cancer, sepsis, and arthritis. QT Sense, founded in 2024 following a decade of research collaboration with the University Medical Center Groningen, will use the ONCO-Q grant to generate the first functional maps of oxidative stress in colorectal tumour models.Tech.euQT Sense closes €4M round to support real-time cell analysisDutch-based startup QT Sense has raised €4 million in total funding, including a €3 million seed round led by Cottonwood Technology Fund, along with follow-on funding from QDNL Participations and an angel investor, plus a €0.6 million ONCO-Q grant and €0.4 million from the Quantum Forward Challenge. The funding will advance Quantum Nuova, a quantum-based platform using fluorescent nanodiamond sensors to monitor cellular stress, oxidative stress, and metabolic changes in living cells at single-cell resolution in real time. With the ONCO-Q grant, the technology will be applied to colorectal cancer research to map oxidative stress and metabolic vulnerabilities in tumour models for future diagnostic and therapeutic development.BebeezQT Sense raises €4 million to develop quantum platform for cancer, sepsis and arthritis research – BeBeez InternationalQT Sense, a Groningen-based biotech startup, raised €4 million to advance its quantum platform, Quantum Nuova, used for real-time cellular stress monitoring in biomedical research. The funding, including grants and investments from venture capitalists and angels, aims to develop the platform for applications in cancer, sepsis, arthritis, and colorectal cancer diagnostics. This development is part of a broader trend of increasing investment in European quantum and biotech startups.ThequantuminsiderQT Sense Raises €4 Million For Quantum Tech That Analyzes Living Cells in Real TimeQT Sense, a Dutch biotech startup, has raised €4 million in total funding — comprising a €3 million seed round led by Cottonwood Technology Fund with participation from QDNL Participations and an angel investor, plus €1 million in non-dilutive grants from ONCO-Q and the Quantum Forward Challenge — to advance its Quantum Nuova quantum sensing platform. The platform uses ultra-sensitive fluorescent nanodiamond quantum sensors to enable real-time measurement of cellular stress, metabolic shifts, and free radical kinetics in living cells at single-cell resolution, a capability that traditional methods studying frozen or dead cells cannot provide. The funding will support the transition of Quantum Nuova from prototype to a deployable discovery platform, with early-access systems to be placed with research and drug discovery partners for applications including colorectal cancer drug development.The Times of IndiaBengaluru's deep-tech startup proposes 'quantum' leap in cancer care - The Economic TimesQuantum Biosciences, a Bengaluru-based deep-tech startup, has developed quantum biosensor technology that detects oxidative stress and cellular damage before symptoms appear, potentially transforming early cancer diagnosis. The technology, created in partnership with Netherlands-based QT Sense and incubated at C-CAMP and IISc Bengaluru, identifies unique "magnetic fingerprints" of oxidative stress at the subcellular level, addressing limitations of existing tools like MRI and PET scans that only detect harm after significant damage. The company plans to spend the next two years working with hospitals in India and abroad to validate the technology and develop clinical diagnostic applications for oncology and other diseases.